Xeris Biopharma Holdings, Inc.

XERS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001867096

SEC filings (opens in a new tab)

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of XERS: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	199	1	201	+3
Shares	87.6M	28	90.6M	+2.96M (+3.4%)
Value	$480.9M	$154	$422.9M	−$58.0M (−12.1%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to XERS in Q2 2025
Institution	Shares	Value	% of portfolio
Polen Capital Management LLC	132,994	$621.1K	0.00%
Campbell & CO Investment Adviser LLC	132,382	$618.2K	0.04%
Simplex Trading, LLC	76,644	$357.0K	0.01%
Savvy Advisors, Inc.	40,465	$189.0K	0.01%
Engineers Gate Manager LP	38,040	$177.6K	0.00%
UBS Asset Management Americas Inc	37,619	$175.7K	0.00%
State of Wyoming	35,206	$164.4K	0.02%
Janney Montgomery Scott LLC	25,200	$118.0K	0.00%
Deerfield Management Company, L.P. (Series C)	22,574	$105.4K	0.00%
Catalyst Funds Management Pty Ltd	21,645	$101.1K	0.03%
Nebula Research & Development LLC	20,751	$96.9K	0.01%
Los Angeles Capital Management LLC	20,382	$95.2K	0.00%
Atom Investors LP	18,155	$84.8K	0.01%
Modern Wealth Management, LLC	17,704	$82.7K	0.00%
Prelude Capital Management, LLC	15,500	$72.4K	0.01%
Clear Street Markets LLC	14,497	$67.7K	0.02%
Quantinno Capital Management LP	12,571	$58.7K	0.00%
Truvestments Capital LLC	3,573	$16.7K	0.00%
Point72 (DIFC) Ltd	1,627	$7.60K	0.00%
Jones Financial Companies LLLP	1,478	$6.95K	0.00%
Aster Capital Management (DIFC) Ltd	1,067	$4.98K	0.00%
Essential Partners LLC	1,065	$4.97K	0.00%
Headlands Technologies LLC	1,052	$4.91K	0.00%
Glenmede Investment Management, LP	975	$4.55K	0.00%
Global Retirement Partners, LLC	700	$3.27K	0.00%
Clearstead Advisors, LLC	564	$2.63K	0.00%

Sold out (23)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of XERS in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Citadel Advisors LLC	1,347,859	$7.40M
PDT Partners, LLC	239,600	$1.32M
Semanteon Capital Management, LP	156,191	$857.5K
Panagora Asset Management Inc	145,526	$798.9K
Fred Alger Management, LLC	134,016	$735.7K
HRT Financial LP	81,112	$445.0K
Corebridge Financial, Inc.	68,698	$377.2K
Bayesian Capital Management, LP	59,300	$325.6K
Mach-1 Financial Group, Inc.	52,530	$288.4K
Verition Fund Management LLC	41,290	$226.7K
Goldstein Advisors, LLC	40,000	$219.6K
Balyasny Asset Management LLC	34,454	$189.2K
Caxton Associates LLP	30,938	$169.8K
Gateway Wealth Partners, LLC	16,800	$92.2K
Aigen Investment Management, LP	16,769	$92.1K
HSBC Holdings PLC	16,205	$88.0K
R Squared Ltd	15,730	$86.4K
Axq Capital, LP	15,348	$84.3K
Oxford Asset Management LLP	13,901	$76.3K
FNY Investment Advisers, LLC	11,500	$63.0K
Lazard Asset Management LLC	11,182	$61.0K
FORA Capital, LLC	11,017	$60.5K
Stephens Consulting, LLC	65	$357

Not filed for Q2 2025 yet (1)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XERS in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Lindbrook Capital, LLC	28	$154